Home › Funds › Graphene Investments SAS › IQV
Graphene Investments SAS position in IQV
IQVIA HLDGS INC · Health Care
Graphene Investments SAS reported holding 14,100 shares of IQV (IQVIA HLDGS INC) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 2.05% of its reported portfolio and ranking #19 among its reported holdings. Graphene Investments SAS has disclosed IQV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Graphene Investments SAS's IQV position evolved
Graphene Investments SAS first disclosed a stake in IQV in Q3 2023 at 15,300 shares (US$3.0M). The position peaked in Q2 2026 at 20,400 shares, worth US$3.9M. Across 13 filings, Graphene Investments SAS increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 14,100 shares valued at US$3.8M — a reduction of -6,300 shares quarter over quarter.. Notable position changes include a 31% trim in Q3 2026 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 15.30K | $3.01M | New |
| Q4 2023 | 13.60K | $3.15M | Reduce |
| Q1 2024 | 13.60K | $3.44M | Hold |
| Q2 2024 | 13.60K | $2.88M | Hold |
| Q3 2024 | 12.30K | $2.91M | Reduce |
| Q4 2024 | 15.00K | $2.95M | Add |
| Q1 2025 | 15.00K | $2.64M | Hold |
| Q2 2025 | 18.40K | $2.90M | Add |
| Q3 2025 | 15.40K | $2.93M | Reduce |
| Q4 2025 | 15.40K | $3.47M | Hold |
| Q1 2026 | 16.90K | $2.88M | Add |
| Q2 2026 | 20.40K | $3.94M | Add |
| Q3 2026 | 14.10K | $3.79M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About IQV and 13F data
IQV (IQVIA HLDGS INC) is a Health Care company. 25 other funds we track also report a position in IQV — the largest reported positions include Harris Associates (Oakmark) (US$2.35B), HARRIS ASSOCIATES L P (US$2.35B), Boston Partners (US$1.17B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding IQV
- Harris Associates (Oakmark) 12.18M sh · $2.35B · Q2 2026
- HARRIS ASSOCIATES L P 12.18M sh · $2.35B · Q2 2026
- Boston Partners 4.37M sh · $1.17B · Q3 2026
- Artisan Partners Limited Partnership 3.46M sh · $930.59M · Q3 2026
- WCM INVESTMENT MANAGEMENT, LLC 2.67M sh · $717.70M · Q3 2026
- LYRICAL ASSET MANAGEMENT LP 1.25M sh · $337.08M · Q3 2026
More on Graphene Investments SAS
FAQ
How long has Graphene Investments SAS held IQV?
Graphene Investments SAS has disclosed IQV holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Graphene Investments SAS's current position in IQV?
As of Q3 2026, Graphene Investments SAS holds 14.10K shares of IQV (IQVIA HLDGS INC), valued at $3.79M, representing 2.05% of its reported portfolio and ranking #19.
Has Graphene Investments SAS been buying or selling IQV?
In the latest 13F filing (Q3 2026), Graphene Investments SAS reduced its position in IQV. The position peaked in Q2 2026 at 20.40K shares.
Which other funds hold IQV?
Other major institutional holders of IQV include Harris Associates (Oakmark), HARRIS ASSOCIATES L P, Boston Partners, among 25 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.